Additional Benzene Ring Containing Patents (Class 514/736)
-
Publication number: 20080249063Abstract: The biological function of skeletal muscle precursor cells in the repair and growth of skeletal muscle in response to exercise is promoted by providing a supplemental composition comprising at least creatine and fucoidin to reinforce biochemical pathways involved in the maintenance of skeletal muscle satellite cells and other myogenic precursors. The composition and method of the present invention induce muscle hypertrophy via satellite cells fusion to muscle fibres and induce a substantially simultaneous replenishment of myogenic precursor cells in response to exercise in a mammal.Type: ApplicationFiled: April 4, 2007Publication date: October 9, 2008Inventors: Marvin A. Heuer, Ken Clement, Shan Chaudhuri, Michele Molino, Philip Apong, Jason Peters
-
Publication number: 20080249136Abstract: An antimicrobial composition containing a cationic polymer having limited antimicrobial activity (such as a hydrophobically-modified quaternary ammonium cellulose ether) and an antimicrobial compound (such as one or more compounds selected from the group consisting of diiodomethyl-para-tolylsulfone, ortho-phenylphenol, sodium pyrithione, zinc pyrithione, 3-iodo-2-propynylbutylcarbamate, 2-methyl-4-isothiazolin-3-one, 1,2-benzisothiazolin-3-one, 2-n-octyl-4-isothiazolin-3-one, 1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride, 2-(4-thiazolyl)-benzimidazole, ?-bromo-?-nitrostyrene, 2,4,4?-trichloro-2-hydroxyphenyl ether, chloroxylenol, chlorocresol, para-tert-amylphenol, N-(4-chlorophenyl)-N?-(3,4 dichlorophenyl)-urea, and para-hydroxybenzoic acid esters). The growth of microorganisms (such as Pseudomonas aeruginosa) can be inhibited by exposing the microorganism to such a composition.Type: ApplicationFiled: October 25, 2006Publication date: October 9, 2008Inventors: Ioana Annis, Charles D. Gartner
-
Publication number: 20080226582Abstract: Disclosed is a composition for improving atopic dermatological diseases comprising magnolol, honokiol or the combination thereof.Type: ApplicationFiled: March 13, 2007Publication date: September 18, 2008Inventors: Deok Hoon Park, Jong Sung Lee, Junho Park, Eunsun Jung, Seong Taek Hong
-
Publication number: 20080199425Abstract: The invention is based on the observation that certain phenols, monophenols or benzenediols, can be metabolized into reactive quinones, in particular ortho-quinones and related reactive intermediates, which is brought about by oxidation of monophenols and benzenediols by proteins exhibiting tyrosinase activity, such as human tyrosinase and the related proteins TRP1 and TRP2. Although the substances and the produced reactive intermediates are toxic and can induce cell death, it is more relevant according to this invention that they function as haptens that become covalently bound to the tyrosinase enzymes, in particular to histidine moieties, in or near the catalytic site of proteins exhibiting tyrosinase activity, such as tyrosinase, TRP1 and TRP2. An immune response is then to be mounted against these haptenized auto-antigens, in order to treat melanocytic malignancies, in particular melanomas.Type: ApplicationFiled: July 28, 2005Publication date: August 21, 2008Applicant: Color Stitching(Stitching Color)Inventor: Wiete Westerhof
-
Patent number: 7411005Abstract: The invention provides A composition for increasing milk production in an animal that includes an active compound chosen from calcium isopropyl cresol, calcium isopropyl-o-cresol, lactic acid, or combinations thereof, and calcium carbonate as a buffering agent. The invention also provides a composition for increasing milk production in an animal that includes about 0.1 wt % to about 15 wt % of the total weight of the composition of active compound, wherein the active compound is chosen from calcium isopropyl cresol, calcium isopropyl-o-cresol, and lactic acid, about 40 wt % to about 75 wt % of the total weight of the composition of calcium carbonate, and about 10 wt % to about 60 wt % of the total weight of the composition of at least one carrier.Type: GrantFiled: February 12, 2003Date of Patent: August 12, 2008Assignee: Van Beek Natural Science, LLCInventor: Dusan Ninkov
-
Publication number: 20080140036Abstract: The present invention relates to a composition for use as an antimicrobial medicament comprising a biocidally active compound. The invention also relates to a medicament comprising at least one biocidally active compound and a fungal cell or fungal cell fragment wherein molecules of the at least one biocidally active compound are encapsulated or partially encapsulated by the fungal cell or fungal cell fragment.Type: ApplicationFiled: January 18, 2005Publication date: June 12, 2008Inventors: Rachael Buck, Michael Edward Donald Crothers, Gordon Nelson
-
Publication number: 20080139668Abstract: Disclosed herein is a pharmaceutical composition for the prevention and treatment of restenosis following a blood vessel injury procedure, comprising obovatol as an active ingredient.Type: ApplicationFiled: December 6, 2007Publication date: June 12, 2008Applicants: Korea Research Institute of Bioscience and Biotechnology, Chungbuk National University Industry-Academic Cooperation FoundationInventors: Byoung Mog Kwon, Yeo-Pyo Yun, Yong Lim, Dong-Woon Kim, Jin-Sook Kwon, Seung-ho Lee, Jin-Tae Hong
-
Patent number: 7365099Abstract: A method for controlling body fat in a human or nonhuman animal includes the step of reducing lipoxygenase activity in an animal. Lipoxygenase activity can be reduced by reducing the enzyme activity or by lowering the enzyme level. Reduced lipoxygenase activity correlates with reduced cell-associated LPL activity and with reduced cellular triacylglyceride level.Type: GrantFiled: May 31, 2001Date of Patent: April 29, 2008Assignee: Wisconsin Alumni Research FoundationInventors: Michael W. Pariza, Yeonhwa Park
-
Publication number: 20070292465Abstract: Binary or greater mixtures of biocides which exist in the form of eutectic blends which range from damp blends to liquid blends are described. Mixtures of phenolic biocides are preferred. The biocides are useful in the formulation of disinfectant compositions for industrial and domestic use.Type: ApplicationFiled: June 16, 2006Publication date: December 20, 2007Inventors: Michael Parkin, Uwe Falk, Cezanne Vielkanowitz
-
Patent number: 7262222Abstract: Ortho phenylphenol or its sodium salt is shown to form synergistic antimicrobial mixtures with nitrogen and aldehyde-containing microbiocides.Type: GrantFiled: January 16, 2003Date of Patent: August 28, 2007Assignee: Verichem, Inc.Inventors: Paul E. Carlson, H. Edwin Nehus
-
Patent number: 7226610Abstract: Non-toxic, naturally derived and economical compositions for treating and preventing bacterial or fungal disease in plants, especially citrus canker, wherein such compositions include various combinations of d-limonene, wax and monohydric alcohol are provided. Methods for making and using such compositions are also provided.Type: GrantFiled: March 30, 2005Date of Patent: June 5, 2007Assignee: Preservation Sciences, Inc.Inventor: Paul Winniczuk
-
Patent number: 7157078Abstract: This invention relates to devices, kits, and methods for eliminating termite colonies. The kits, devices, and methods employ a termiticidal bait matrix containing a) a termiticide selected such that the termiticide causes death to about 50 to about 100% of termites within about 24 to about 84 days after the termites begin to ingest the termiticide or the bait matrix comprising the termiticide, b) a cellulose containing material, and c) water. The termiticidal bait matrix can be used in a bait station installed in the ground. The kits are suitable to be used by consumers in their homes.Type: GrantFiled: February 2, 2004Date of Patent: January 2, 2007Assignee: The University of Florida Research Foundation, Inc.Inventors: Philip Frederick Brode, III, Garry Steven Garren, Leo Timothy Laughlin, Randall Stryker Matthews, Dale Edwin Barker, Daniel James Kinne, Gary Eugene McKibben, Christopher Miles Miller, Timothy Robert Probst
-
Patent number: 7135600Abstract: The present invention relates to novel compounds of Formula (I), to a process for their manufacture, to pharmaceutical compositions containing them, and to their use in therapy, in particular their use in the prophylaxis and treatment of respiratory diseases.Type: GrantFiled: February 11, 2002Date of Patent: November 14, 2006Assignee: Glaxo Group LimitedInventors: Keith Biggadike, Diane Mary Coe, Stephen Barry Guntrip, Brian Edgar Looker, Panayiotis Alexandrou Procopiou
-
Patent number: 7109164Abstract: New thyroid receptor ligands are provided which have the general formula in which: X is —O—, —S—, —CH2—, —CO—, or —NH—; Y is —(CH2)n— where n is an integer from 1 to 5, or cis- or trans-ethylene; R1 is halogen, trifluoromethyl, or alkyl of 1 to 6 carbons or cycloalkyl of 3 to 7 carbons; R2 and R3 are the same or different and are hydrogen, halogen, alkyl of 1 to 4 carbons or cycloalkyl of 3 to 6 carbons, at least one of R2 and R3 being other than hydrogen; R4 is hydrogen or lower alkyl; R5 is hydrogen or lower alkyl; R6 is carboxylic acid, or esters or prodrugs; R7 is hydrogen or an alkanoyl or an aroyl. In addition, a method is provided for preventing, inhibiting or treating a disease associated with metabolism dysfunction or which is dependent upon the expression of a T3 regulated gene, wherein a compound as described above is administered in a therapeutically effective amount.Type: GrantFiled: August 30, 2004Date of Patent: September 19, 2006Assignee: Bristol-Myers Squibb CompanyInventors: Todd J. Friends, Denis E. Ryono, Minsheng Zhang
-
Patent number: 7037945Abstract: The present invention provides a method of inhibiting the formation of pseudorabies particles in a host cell. The method involves administering an effective amount of a poly-hydroxylated stilbene, particularly resveratrol, to a herpes virus infected host cell. The present invention also provides a method of reducing or inhibiting the growth of Neisseria gonorrhea and Neisseria meningiditis in vitro and in vivo. The method comprises administering a composition comprising a therapeutically effective amount of a tri-hydroxylated stilbene to a growth surface which has come into contact or could come into contact with the bacterium.Type: GrantFiled: December 11, 2001Date of Patent: May 2, 2006Assignee: Northeastern Ohio Universities College of MedicineInventor: John Docherty
-
Patent number: 6992111Abstract: A fungicidal composition and method of treating plant diseases using a compound of formula I where X is flouro, chloro and trifluromethyl.Type: GrantFiled: September 2, 2004Date of Patent: January 31, 2006Assignee: Valent BioSciences CorporationInventors: Daniel F. Heiman, Peter D. Petracek, Judith A. Fugiel, Prem Warrior
-
Patent number: 6943196Abstract: An NF-?B inhibitor having as an active ingredient a benzoquinone derivative represented by the general formula (1) wherein R1, R2, and R3 are each independently H, alkyl having 1 to 5 carbons, or alkoxy having 1 to 5 carbons; R4 is H, hydroxymethyl, alkyl, or carboxyl which is optionally esterified or amidated; Z is represented by the formula (A); and, n is an integer from 0 to 6, or its hydroquinone form or a pharmaceutically acceptable salt thereof.Type: GrantFiled: March 19, 1999Date of Patent: September 13, 2005Assignee: Daiichi Suntory Pharma Co., Ltd.Inventors: Yoichi Nunokawa, Kenji Suzuki, Masayuki Saitoh
-
Patent number: 6878751Abstract: A method is provided for treating inflammatory respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD). The method involves administration, preferably oral or pulmonary administration, of an active agent selected from the group consisting of resveratrol, pharmacologically acceptable salts, esters, amides, prodrugs and analogs thereof, and combinations of any of the foregoing. Pharmaceutical formulations for use in conjunction with the aforementioned method are provided as well.Type: GrantFiled: October 19, 2000Date of Patent: April 12, 2005Assignees: Imperial College of Science Technology and Medicine, Imperial College Innovations LimitedInventors: Louise Elizabeth Donnelly, Peter John Barnes
-
Patent number: 6855353Abstract: A pharmaceutical composition for prevention and treatment of cancer, cardiovascular disease and antioxidation contains resveratol. The new method of process for producing resveratol is extracted resveratol from oil residue and stems of peanuts or stems of other cheap herbs. Derivates of resveratol include procyanidins, polydatin, peceid, anthraglycoside, emodin, chrysophanol and quercetin.Type: GrantFiled: March 8, 2002Date of Patent: February 15, 2005Inventor: Yaguang Liu
-
Patent number: 6800605Abstract: New thyroid receptor ligands are provided which have the general formula in which: X is —O—, —S—, —CH2—, —CO—, or —NH—; Y is —(CH2)n— where n is an integer from 1 to 5, or cis- or trans-ethylene; R1 is halogen, trifluoromethyl, or alkyl of 1 to 6 carbons or cycloalkyl of 3 to 7 carbons; R2 and R3 are the same or different and are hydrogen, halogen, alkyl of 1 to 4 carbons or cycloalkyl of 3 to 6 carbons, at least one of R2 and R3 being other than hydrogen; R4 is hydrogen or lower alkyl; R5 is hydrogen or lower alkyl; R6 is carboxylic acid, or esters or prodrugs; R7 is hydrogen or an alkanoyl or an aroyl. In addition, a method is provided for preventing, inhibiting or treating a disease associated with metabolism dysfunction or which is dependent upon the expression of a T3 regulated gene, wherein a compound as described above is administered in a therapeutically effective amount.Type: GrantFiled: January 16, 2001Date of Patent: October 5, 2004Assignee: Bristol-Myers Squibb CompanyInventors: Todd J. Friends, Denis E. Ryono, Minsheng Zhang
-
Publication number: 20040137446Abstract: Discovery and characterization of an apicomplexan Fab I gene and encoded enzyme and discovery of the triclosan as a lead compound, provide means to rationally design novel inhibitory compositions useful for prevention and treatment of apicomplexan related diseases.Type: ApplicationFiled: June 18, 2003Publication date: July 15, 2004Inventors: Rima McLeod, Stephen P. Muench, John B. Rafferty, Dennis E. Kyle, Ernest J. Mui, Michael J. Kirisits, Douglas G. Mack, Craig W. Roberts, Benjamin U. Samuel, Russell E. Lyons, Wilbur K. Milhous, Sean Prigge, David W. Rice
-
Patent number: 6730329Abstract: One aspect of the invention relates to anti-viral composition containing at least one zinc compound and at least one phenolic antioxidant (and optionally other ingredients such as at least one analgesic) at least one hydrocarbyl containing compound, and water. Another aspect of the invention relates to a method of treating lesionous symptoms of a viral infection involving applying an effective amount of the zinc containing anti-viral composition to the lesions.Type: GrantFiled: February 26, 2002Date of Patent: May 4, 2004Inventor: Jeffrey B. Smith
-
Patent number: 6730294Abstract: A method of forming a water soluble biocidal film on a solid household, food preparation, or medical surface, which protects the solid surface against reinfection by microorganisms, includes providing a liquid biocidal composition comprised of, based on total weight of the liquid biocidal composition from 0.1 to 5.0 wt. % of a phenolic biocide; from an amount effective to impart film-forming properties to the liquid biocidal composition up to 8 wt. % of a polyvinyl pyrrolidone polymer or copolymer; and an aqueous alcoholic solvent in which the phenolic biocide and the polyvinylpyrrolidone polymer or copolymer are dissolved; treating the solid surface with the liquid biocidal composition; and evaporating the aqueous alcoholic solvent to provide a clear film, wherein a ratio of the phenolic biocide to the polyvinylpyrrolidone polymer or copolymer is selected to range from 1:0.8 to 1:3 so that a complex there between is provided which dries clear.Type: GrantFiled: March 31, 2000Date of Patent: May 4, 2004Assignee: Novapharm Research (Australia) Pty LimitedInventor: Steven Kritzler
-
Patent number: 6716421Abstract: This invention relates to devices, kits, and methods for eliminating termite colonies. The kits, devices, and methods employ a termiticidal bait matrix containing a) a termiticide selected such that the termiticide causes death to about 50 to about 100% of termites within about 24 to about 84 days after the termites begin to ingest the termiticide or the bait matrix comprising the termiticide, b) a cellulose containing material, and c) water. The termiticidal bait matrix can be used in a bait station installed in the ground. The kits are suitable to be used by consumers in their homes.Type: GrantFiled: March 5, 2001Date of Patent: April 6, 2004Assignee: University of Florida Research Foundation, Inc.Inventors: Philip Frederick Brode, III, Garry Steven Garrett, Leo Timothy Laughlin, Randall Stryker Matthews, Dale Edwin Barker, Daniel James Kinne, Gary Eugene McKibben, Christopher Miles Miller, Timothy Robert Probst
-
Patent number: 6703421Abstract: A method for prevention or treating myocarditis, dilated cardiomyopathy and heart failure comprising administering to a patient in need of such treatment a NF-&kgr;B inhibitor in a therapeutically effective amount, wherein said NF-&kgr;B inhibitor is a benzoquinone derivative represented by the following formula (I): wherein R1, R2 and R3 are each independently a hydrogen atom, an alkyl group having 1 to 5 carbons or an alkoxy group having 1 to 5 carbons; R4 is a hydrogen atom, a hydroxymethyl group, an alkyl group, or a carboxyl group which is optionally esterified or amidated; Z is and n is an integer from 0 to 6, or its hydroquinone form, or a pharmaceutically acceptable salt thereof, is provided.Type: GrantFiled: May 17, 2001Date of Patent: March 9, 2004Assignee: Daiichi Suntory Pharma Co., Ltd.Inventors: Yoichi Nunokawa, Akira Matsumori
-
Patent number: 6689922Abstract: The invention concerns novel bi-aromatic compounds having the formula: which are analogs of vitamin D, the process of preparing them, as well as their use in pharmaceutical compositions in human or veterinary medicine, particularly in dermatology, cancer treatment, treatment of auto-immune diseases, and in organ or tissue transplants. Cosmetic compositions and methods of use are also included.Type: GrantFiled: July 26, 2001Date of Patent: February 10, 2004Assignee: Galderma Research & Development S.N.C.Inventor: Jean-Michel Bernardon
-
Patent number: 6649193Abstract: The invention is directed to therapeutic antioxidant compositions which are enhanced by the stabilized atomic hydrogen; one of the most potent antioxidants. Such products can be used for prophylactic and therapeutic purposes in treatment of cancer, diabetes, autoimmune diseases, neurodegenerative diseases, cardiovascular diseases, skin diseases etc. The products described can be used independently or in combination with other drugs and treatment modalities. The products can also be used as dietetic products to aid in desired weigh loss. The described products can also be used to prevent oxidative and free radical damage to food and oxidation-prone industrial products. The invention also describes the methods to produce and stabilize atomic hydrogen and prepare and use such stabilized/encaged atomic hydrogen enhanced antioxidant compositions.Type: GrantFiled: June 9, 2000Date of Patent: November 18, 2003Assignee: Henceforth Hibernia Inc.Inventor: Miroslav Colic
-
Publication number: 20030207945Abstract: A antimicrobial compound, compositions containing the same, and method of using the same for reducing the presence of microorganism on a substrate or in a fluid environment comprising an antimicrobial effective carrier and at least one antimicrobial compounds including non-halogenated phenyl substituted phenol compounds.Type: ApplicationFiled: April 28, 2003Publication date: November 6, 2003Inventors: David Scott Harper, Robert A. Coburn, Constantine Georgiades, Andre Soshinsky, Marianne D. Huntley
-
Publication number: 20030187007Abstract: The present invention is directed in part towards methods of modulating the function of protein kinases with phenol- and hydroxynaphthalene-based compounds. The methods incorporate cells that express a protein kinase. In addition, the invention describes methods of preventing and treating protein kinase-related abnormal conditions in organisms with a compound identified by the invention. Furthermore, the invention pertains to phenol- and hydroxynaphthalene-based compounds and pharmaceutical compositions comprising these compounds.Type: ApplicationFiled: May 28, 2002Publication date: October 2, 2003Inventors: Sheldon Xiaodong Cao, Pierre-Yves Bounaud, Xiaohua Chen, Hyun-Ho Chung, Sunil Kumar KC, Changhee Min, Jae Young Yang, Melissa C. Long
-
Patent number: 6610750Abstract: A method of treating osteoarthritis, which is effective not only at targeting the symptoms of the disease, but also in interrupting, preventing, and controlling cartilage destruction, to thereby favorably alter the course of the disease, comprising the administration of an effective amount of rhein or a rhein derivative, preferably diacerein, either alone or in combination with at least one member selected from the group consisting of analgesics, antipyretics, cortico-steroids, anti-inflammatory agents, cyclooxygenase-2 inhibitors, and inflammatory cytokine inhibitors, to a subject in need of such treatment.Type: GrantFiled: September 15, 2000Date of Patent: August 26, 2003Assignee: Laboratoires NegmaInventors: Suzy Charbit, Francois Schutze, Alain Taccoen, Jean-Pierre Pelletier, Diego Provvedini
-
Publication number: 20020169206Abstract: A class of substituted biphenyl compounds is described for use in treating inflammation and inflammation-related disorders.Type: ApplicationFiled: January 30, 2001Publication date: November 14, 2002Applicant: G.D. Searle & Co.Inventors: David B. Reitz, James J. Li, Monica B. Norton
-
Publication number: 20020168397Abstract: This invention is to provide an agent for therapy and prevention of allergic diseases which has no adverse action, shows a high safety even by administration for a long period and is able to be utilized to food and/or beverage, cosmetics, etc. which are used daily. To be specific, it provides antiallergic agent and anti-inflammatory agent characterized in containing at least one polyphenol selected from strictinin and methylated derivatives thereof as an effective ingredient; a method for the addition of an antiallergic agent for oral administration or an anti-inflammatory agent for oral administration which is characterized in containing at least one polyphenol selected from strictinin and methylated derivatives thereof as an effective ingredient to food and/or beverage for prevention, suppression and mitigation of allergic symptoms or inflammatory symptoms.Type: ApplicationFiled: February 8, 2001Publication date: November 14, 2002Inventors: Kenkou Tsuji, Mari Yamamoto, Keiko Kawamoto, Hirofumi Tachibana
-
Patent number: 6475526Abstract: One aspect of the invention relates to anti-viral composition containing at least one zinc compound and at least one phenolic antioxidant (and optionally other ingredients such as at least one analgesic) at least one hydrocarbyl containing compound, and water. Another aspect of the invention relates to a method of treating lesionous symptoms of a viral infection involving applying an effective amount of the zinc containing anti-viral composition to the lesions.Type: GrantFiled: June 5, 2001Date of Patent: November 5, 2002Inventor: Jeffrey B. Smith
-
Patent number: 6461591Abstract: A pressure-liquefied propellant mixture for aerosols, comprising a fluorinated alkane, in particular 1,1,1,2-tetrafluoroethane and/or 1,1,1,2,3,3,3-heptafluoropropane, and carbon dioxide, makes possible an improvement of the wetting properties of pharmaceutically active compounds, with which the formulation problems existing with hydrofluoroalkanes in relation to suspension as well as solution aerosols can be overcome and thus improved medicinal aerosol formulations can be obtained. With the aid of carbon dioxide, it is also possible to specifically influence the pressure and thus the particle size distribution and also by displacement of oxygen from the hydrofluoroalkanes to improve the storage stability of oxidation-sensitive active compounds.Type: GrantFiled: August 4, 1999Date of Patent: October 8, 2002Assignee: Jago Research AGInventors: Manfred Keller, Kurt Herzog
-
Patent number: 6455541Abstract: The present invention focuses upon a method for inhibiting bone resorption. This method involves administering a 5-lipoxygenase inhibitor to a subject in an amount inhibiting the effects of an osteoclast-stimulating factor. When the production of the osteoclast-stimulating factors such as PTH, PTHrp, IL-1, TNF, LT, 1,25(OH)2D3 or other factors which may stimulate the production of 5-LO metabolites via the 5-lipoxygenase pathway is inhibited, bone resorption markedly declines. The direct osteoclast-stimulating factors include leukotriene, peptidoleukotriene and 5-hydroxyeicosatetraenoic acid. Other factors yet to be identified or previously known may also be 5-lipoxygenase metabolites that stimulate bone resorption. While 5-lipoxygenase inhibitors may be substrate analogs or allosteric inhibitors, a substance which inhibits the activity of this enzyme may utilize other mechanisms (e.g., inhibition of 5-LO biosynthesis) and nevertheless function to inhibit bone resorption.Type: GrantFiled: May 8, 2000Date of Patent: September 24, 2002Assignee: Board of Regents, The University of Texas SystemInventors: Lynda F. Bonewald, G. R. Mundy, Wolf E. Gallwitz
-
Patent number: 6448294Abstract: A method of treating symptoms linked to menopause in warm-blooded animals by administering to warm-blooded animals in need thereof an amount of a compound of the formula wherein the substituents are defined as in the application sufficient to treat said symptoms.Type: GrantFiled: February 13, 2002Date of Patent: September 10, 2002Assignee: Aventis Pharma S.A.Inventor: Dominique Lesuisse
-
Patent number: 6440391Abstract: A method of managing snoring is provided by the instillation orally of a solution containing 1-20% methylsulfonylmethane by weight dissolved in water so as to cover the mucous membranes of the orophyrnx. Preferably, the solution has between 10%-15% by weight methylsulfonylmethane. The solution may be buffered, and/or a flavoring may be included. The method prefers that instillation occur as close to the sleep event as possible, and it should be at least within thirty (30) minutes to fifteen (15) minutes before a person retires for sleep. The solution may be introduced by spray or drop-wise, and a product packaging the solution in a suitable container is described.Type: GrantFiled: June 2, 2000Date of Patent: August 27, 2002Assignee: Elstan CorporationInventor: Stanley W. Jacob
-
Patent number: 6414037Abstract: A method is provided for preventing or treating skin conditions, disorders or diseases, such as may be associated with or caused by inflammation, sun damage or natural aging. The method involves administration, preferably topical administration, of an active agent selected from the group consisting of resveratrol, pharmacologically acceptable salts, esters, amides, prodrugs and analogs thereof, and combinations of any of the foregoing. Pharmaceutical formulations for use in conjunction with the aforementioned method are provided as well.Type: GrantFiled: October 29, 1999Date of Patent: July 2, 2002Assignee: PharmascienceInventors: John M. Pezzuto, Richard C. Moon, Mei-Shiang Jang, Aomar Ouali, Shengzhao Lin, Karla Slowing Barillas
-
Patent number: 6407142Abstract: The present invention relates to the use of 3,5-dihydroxystilbene or 3-hydroxystilbene and/or derivatives thereof as deodorant active agents in the preparation of cosmetic compositions, to the deodorant cosmetic compositions containing these compounds, to the use of the compositions for human topical application, and to novel stilbene derivatives substituted in position 3 and to the cosmetic compositions comprising them.Type: GrantFiled: February 16, 2000Date of Patent: June 18, 2002Assignee: L'Oreal S.A.Inventors: Christophe Courbriere, Francis Pruche, Sylvain Kravtchenko
-
Patent number: 6403652Abstract: A method for inhibiting methicillin drug resistant bacteria using a phenolic compound.Type: GrantFiled: June 30, 2000Date of Patent: June 11, 2002Assignee: Colgate-Palmolive CompanyInventors: John Brahms, Bruce Nascimbeni, Sukhvinder Sandhu
-
Patent number: 6391925Abstract: A liquid composition of phenolic compounds can be formed in the substantial absence of a solvent and a surfactant. This composition includes at least one substituted phenol and a halo-substituted phenol. In one embodiment, the composition includes benzylchlorophenol and at least one of phenylphenol and tert-pentylphenol. In another embodiment, the composition includes benzylchlorophenol, phenylphenol, and tert-pentylphenol. The composition may be useful for preparing an antimicrobial material. A liquid phenolic composition can be prepared by forming a composition having at least one substituted phenol and a halo-substituted phenol in the substantial absence of a solvent and surfactant and mixing the composition until a liquid phenolic composition is formed.Type: GrantFiled: January 13, 2000Date of Patent: May 21, 2002Assignee: Ecolab Inc.Inventor: Kim R. Smith
-
Patent number: 6369115Abstract: A dry powder formulation for treatment of pulmonary conditions, via inhalation, includes an effective amount of formoterol or a salt or solvate thereof, in a dry powder form, an effective amount of fluticasone, in a dry powder form, and an excipient. A method for preparing a physically stable dry powder formulation for inhalation includes the steps of micronizing a first active polar drug, a second active non-polar drug, and a polar excipient. The second non-polar active drug is first blended with the excipient to form an intermediate mixture. The intermediate mixture is then blended with the first active polar drug. The increased separation of the polar drug and polar excipient stabilizes the formulation.Type: GrantFiled: March 20, 2000Date of Patent: April 9, 2002Assignee: Dura Pharmaceuticals, Inc.Inventor: Gary Ward
-
Patent number: 6365634Abstract: This invention discloses methods for treating inflammation by inhibiting the production of pro-inflammatory metabolites via the cyclooxygenase and/or lipoxygenase pathways, comprising administering 4-cumylphenol or salts or solvates thereof.Type: GrantFiled: December 11, 1998Date of Patent: April 2, 2002Assignee: C-P Technology Limited PartnershipInventors: Brett A. Russell, John D. Miller, John R. Cashman, Sirimevan A. Weerawarna
-
Patent number: 6361815Abstract: Provided are products including trihydroxystilbenes and glycosylated derivatives thereof. Also provided are compositions containing these products with an aqueous solvent, particularly and alcohol-water mixture, and reverse phase chromatographic methods for isolating and purifying the compositions from plant materials. The products have biological activity, including anti-tumor activity.Type: GrantFiled: December 21, 1998Date of Patent: March 26, 2002Assignee: Pure World Botanicals, Inc.Inventors: Bo Lin Zheng, Calvin Hyungchan Kim, Kan He, Qun Yi Zheng
-
Publication number: 20020028846Abstract: The invention provides a composition suitable for topical application comprising: an effective amount of a prostaglandin, a polymer thickener, a lipophilic component, and a buffer system. In another embodiment, the invention provides a composition suitable for topical application comprising: an effective amount of a vasoactive agent, a polymer thickener, a lipophilic component, and a buffer system. The invention also provides methods of ameliorating female sexual dysfunction. Also provided are methods of increasing female sexual arousal and methods of enhancing female sexual response.Type: ApplicationFiled: December 10, 1998Publication date: March 7, 2002Inventors: JAMES L. YEAGER, NADIR BUYUKTIMKIN, SERVET BUYUKTIMKIN
-
Patent number: 6335004Abstract: Reduced odor or odorless antimicrobial phenolic compositions containing collagen amino acids and methods of use are disclosed. The compositions can be formulated for use as a soap, emollient or hard surface cleaner. In one particularly advantageous embodiment, a composition of the invention is formulated as an antimicribial cleaner including an amount of collagen amino acids sufficient to decrease the odor of the phenolic compound below its initial levels and an amount of at least one of a soap or hard surface cleaner.Type: GrantFiled: May 31, 2000Date of Patent: January 1, 2002Assignee: Ecolab Inc.Inventor: Kim R. Smith
-
Patent number: 6280707Abstract: An oral prophalaxis paste includes a preselected grade and amount of abrasive material such as pumice clay or diatimoceous earth. The abrasive material is moistened with water and a moisture retention agent such as glycerin is included. A curing system is employed, such as using sodium silicate and methyl salicylate. The formulation provides antimicrobial properties by the inclusion of triclosan.Type: GrantFiled: December 15, 1998Date of Patent: August 28, 2001Assignee: Dentsply International Inc.Inventors: Kenneth S. Peterson, James M. Sherman, Connie Chilcott, Tse-Chong Wu
-
Patent number: 6218431Abstract: Substituted biphenyls having glucagon receptor antagonistic activity. Claimed compounds have the formula wherein R1a and R1b independently represent (C1-C6) alkyl; R2 represents (C1-C10) alkyl or substituted (C1-C10) alkyl wherein the substituents are independently from 1 to 3 of —SR7; R7 represents phenyl, or substituted phenyl wherein the substituents are independently 1-5 of halogen, trifluoromethyl, (C1-C6) alkyl, (C1-C6) alkoxy, nitro, cyano, or hydroxyl; R3 represents substituted (C1-C6) alkyl wherein the substituents are 1-2 hydroxyl groups; G represents a substituent selected from the group consisting of halogen, (C1-C6) alkyl, and OR4 wherein R4 is H or (C1-C6) alkyl; and y is 0 or an integer of 1-3. Pharmaceutical compositions containing such compounds and methods of treatment of glucagon-mediated conditions by administering such compounds are also claimed.Type: GrantFiled: July 31, 1997Date of Patent: April 17, 2001Assignees: Bayer Corporation, Bayer AktiengesellschaftInventors: William R. Schoen, Gaetan H. Ladouceur, James H. Cook, II, Timothy G. Lease, Donald J. Wolanin, Richard H. Kramss, Donald L. Hertzog, Martin H. Osterhout
-
Patent number: 6147119Abstract: Compounds of formula (I), wherein [X] represents aromatic carbocyclic rings (A) and (B), where R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6 and R.sub.7 are as defined in the description, salts thereof, a method and intermediates for preparing same, the use thereof as drugs, and pharmaceutical compositions containing same, are disclosed.Type: GrantFiled: September 28, 1998Date of Patent: November 14, 2000Assignee: Hoechst Marion RousselInventor: Dominique Lesuisse
-
Patent number: 6139879Abstract: The present invention relates to heavy metal chelate compositions, which are used as fungicides and bactericides, and methods of using the compositions. In particular, the present invention relates to a chelate, that is an EDDHA (copper-ethylenediamine-di-o-hydroxyphenylacetic acid), combined with a heavy metal, including iron, tin, zinc, manganese, copper, and combinations thereof.Type: GrantFiled: August 31, 1999Date of Patent: October 31, 2000Assignee: Foliar Nutrients, Inc.Inventor: John B. Taylor